Title : Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets.

Pub. Date : 2021 Aug 30

PMID : 34483461






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The objective of our study is to unravel the binding mechanism of the Food and Drug Administration (FDA)-approved dexamethasone (Dex) and boceprevir (Boc) drugs with selected COVID-19 protein targets SARS-CoV-2 spike protein C-terminal domain (spike-CTD), main protease (Mpro), and interleukin-6 (IL-6). Dexamethasone interleukin 6 Homo sapiens
2 The objective of our study is to unravel the binding mechanism of the Food and Drug Administration (FDA)-approved dexamethasone (Dex) and boceprevir (Boc) drugs with selected COVID-19 protein targets SARS-CoV-2 spike protein C-terminal domain (spike-CTD), main protease (Mpro), and interleukin-6 (IL-6). Dexamethasone interleukin 6 Homo sapiens
3 The objective of our study is to unravel the binding mechanism of the Food and Drug Administration (FDA)-approved dexamethasone (Dex) and boceprevir (Boc) drugs with selected COVID-19 protein targets SARS-CoV-2 spike protein C-terminal domain (spike-CTD), main protease (Mpro), and interleukin-6 (IL-6). Dexamethasone interleukin 6 Homo sapiens